Clinical Trial Update: Limbal Stem Cell Derived Exosome (LSC-Exo) Eye Drop for Treatment of Dry Eye [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for a limbal stem cell-derived exosome eye drop (LSC-Exo) for dry eye; currently recruiting in Iran.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndrome

Drugs mentioned

• LSC-Exo Eye Drop (limbal stem cell-derived exosome eye drop)

Snippet

Sponsor: Iran University of Medical Sciences | Conditions: Dry Eye Syndromes | Phase 1 | Status: RECRUITING